Pfizer Corporation

Zoetis Services LLC

Ohio State Innovation Foundation

Zoetis LLC

Mark J Mitton-Fry

Andrea Joy Gonzales

Donald Wayne Mann

Jerry W Bowman

Matthew Joseph Birchmeier

Pamela J Berlinski

Steven Glenn Kamerling

Matthew Frank Brown

Mark Edward Flanagan

Joseph Walter Strohbach

Ruth Elizabeth TenBrink

Rayomand Jal Unwalla

Neelu Kaila

Timothy Allan Johnson

John David Trzupek

Michael L Vazquez

Mihir D Parikh

Ashley Edward Fenwick

Seungil Han

Manjinder Singh Lall

Mark Stephen Plummer

Hud Lawrence Risley

Veerabahu Shanmugasundaram

Ruth E Tenbrink

Jeremy T Starr

Disclosed are Type II Topoisomerase Inhibitors, analogs thereof, pharmaceutical compositions thereof and methods of making and using these compounds and compositions. Methods of using the disclosed compounds to treat infections, such as MRSA, MDR, and other pathogens are also described.

Type II topoisomerase inhibitors and methods of making and using thereof

Described herein are pyrrolo{2,3-d}pyrimidine derivatives, their use as Janus Kinase (JAK) inhibitors, and pharmaceutical compositions containing them.

Pyrrolo[2,3-D]pyrimidine derivatives

Described herein is pyrrolo{2,3-d}pyrimidine compounds, their use as Janus Kinase (JAK) inhibitors, pharmaceutical compositions containing this compounds, and methods for the preparation of these compounds.

Pyrrolo[2,3-D]pyrimidine compounds

Pyrrolo[2,3-d]pyrimidine compounds

Described herein is pyrrolo{2,3-}pyrimidine compounds, their use as Janus Kinase (JAK) inhibitors, pharmaceutical compositions containing this compounds, and methods for the preparation of these compounds.

[object Object]

Growing community of inventors

Clinton, CT, United States of America

Mark J Mitton-Fry